A case of anti-NMDAR encephalitis presented hypotensive shock during plasma exchange

Brain Dev. 2016 Apr;38(4):427-30. doi: 10.1016/j.braindev.2015.10.009. Epub 2015 Oct 31.

Abstract

We are reporting on a case of pediatric anti-NMDAR encephalitis with autonomic instability. The patient showed little response to first-line treatment of steroid and IVIG. We initiated plasma exchange, also a first-line treatment. This worsened his autonomic instability, resulting in hypotensive shock. He responded well to rituximab and cyclophosphamide, second-line therapies. Anti-NMDAR encephalitis is often accompanied by autonomic instability. Our and other reported cases, raise the question of plasma exchange as a first-line therapy for pediatric NMDAR encephalitis, which is frequently accompanied by autonomic instability. Plasma exchange should be performed cautiously in such patients.

Keywords: Anti-NMDAR encephalitis; Autonomic instability; Cyclophosphamide; Plasmapheresis; Rituximab.

Publication types

  • Case Reports

MeSH terms

  • Anti-N-Methyl-D-Aspartate Receptor Encephalitis / complications
  • Anti-N-Methyl-D-Aspartate Receptor Encephalitis / pathology
  • Anti-N-Methyl-D-Aspartate Receptor Encephalitis / therapy*
  • Brain / pathology
  • Child
  • Cyclophosphamide / therapeutic use
  • Humans
  • Hypotension / complications
  • Immunosuppressive Agents / therapeutic use
  • Immunotherapy
  • Male
  • Plasma Exchange / adverse effects*
  • Plasmapheresis / adverse effects
  • Rituximab / therapeutic use
  • Shock / complications
  • Treatment Outcome

Substances

  • Immunosuppressive Agents
  • Rituximab
  • Cyclophosphamide